Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Dow
Colorcon
Medtronic
Express Scripts
Merck
Harvard Business School

Last Updated: November 17, 2019

DrugPatentWatch Database Preview

PRASUGREL Drug Profile

See Plans and Pricing

« Back to Dashboard

Which patents cover Prasugrel, and what generic alternatives are available?

Prasugrel is a drug marketed by Accord Hlthcare, Amneal Pharms, Aurobindo Pharma Ltd, Hec Pharm, Mylan, Panacea Biotec Ltd, and Uspharma Windlas. and is included in seven NDAs.

The generic ingredient in PRASUGREL is prasugrel hydrochloride. There are nineteen drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the prasugrel hydrochloride profile page.

Drug patent expirations by year for PRASUGREL
Drug Prices for PRASUGREL

See drug prices for PRASUGREL

Recent Clinical Trials for PRASUGREL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
AdvicePharma GroupPhase 4
Federico II UniversityPhase 4
Janssen, LPPhase 4

See all PRASUGREL clinical trials

Pharmacology for PRASUGREL
Synonyms for PRASUGREL
[5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxidanylidene-ethyl]-6,7-dihydro-4H-thieno[3,2-c]pyridin-2-yl] ethanoate
[5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxo-ethyl]-6,7-dihydro-4H-thieno[3,2-c]pyridin-2-yl] acetate
[5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-6,7-dihydro-4H-thieno[3,2-c]pyridin-2-yl] acetate
[5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-6,7-dihydro-4H-thieno[4,5-c]pyridin-2-yl] acetate
150322-43-3
2-[2-(Acetyloxy)-6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]-1-cyclopropyl-2-(2-fluorophenyl)ethanone
2-Acetoxy-5-(alpha-cyclopropylcarbonyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c] pyridine
2-acetoxy-5-(alpha-cyclopropylcarbonyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine
2-Acetoxy-5-(alpha-cyclopropylcarbonyl-2-fluorobenzyl)4,5,6,7-tetrahydrothieno[3,2-c]pyridine
2-acetyloxy-5-(alpha-cyclopropylcarbonyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine
2-acetyloxy-5-(alpha-cycloproylcarbonyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-C]pyridine
322P433
5-(2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate
5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate
5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4H,5H,6H,7H-thieno[3,2-c]pyridin-2-yl acetate
A809033
AB0005241
AB01274761_02
AB01274761-01
AB1008453
ABP000379
AC-1640
AC1OCFGI
acetic acid [5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-6,7-dihydro-4H-thieno[3,2-c]pyridin-2-yl] ester
Acetic acid 5-[2-cyclopropyl-1-(2-fluoro-phenyl)-2-oxo-ethyl]-4,5,6,7-tetrahydro-thieno[3,2-c]pyridin-2-yl ester
ACN-040194
ACT06208
AK327587
AKOS015841187
AM20090728
AN-605
API0003912
BC683564
BCP01882
C-58278
CHEBI:87723
CHEMBL1201772
CP0097
CS 747
CS-0657
CS-747
DB06209
DTGLZDAWLRGWQN-UHFFFAOYSA-N
Effient
Efient
EN002851
ETH051
Ethanone, 2-(2-(acetyloxy)-6,7-dihydrothieno(3,2-c)pyridin-5(4H)-yl)-1-cyclopropyl-2-(2-fluorophenyl)-
Ethanone, 2-[2-(acetyloxy)-6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]-1-cyclopropyl-2-(2-fluorophenyl)-
FC1274
FD7194
FT-0650150
GTPL7562
HMS3604B09
HMS3654D09
HSDB 7995
HY-15284
I06-2111
KB-40650
KS-00000XJY
KS-5301
LY-640315
LY640315
MCULE-1302242257
MLS003882595
MLS006012001
MolPort-006-395-740
NCGC00188690-01
NCGC00188690-02
P2040
PB23765
Prasita
Prasugrel (Effient)
Prasugrel [INN:BAN]
Prasugrel, >=98% (HPLC)
prasugrel, 2-[2-(Acetyloxy)-6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]-1-cyclopropyl-2-(2-fluorophenyl)ethanone
Prasugrel, 98%
Prasugrel/Effient
PubChem19523
Q-101872
Q-1607
RL01920
s1258
SB20805
SC-20714
SCHEMBL14112007
SCHEMBL245032
SMR002533665
STL232602
SW219175-1
W0064
ZLA0001
zlchem 1

US Patents and Regulatory Information for PRASUGREL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Accord Hlthcare PRASUGREL prasugrel hydrochloride TABLET;ORAL 205987-001 Feb 2, 2018 AB RX No No   Start Trial   Start Trial   Start Trial
Hec Pharm PRASUGREL prasugrel hydrochloride TABLET;ORAL 206021-001 Jan 16, 2019 AB RX No No   Start Trial   Start Trial   Start Trial
Amneal Pharms PRASUGREL prasugrel hydrochloride TABLET;ORAL 205913-002 Jun 19, 2018 AB RX No No   Start Trial   Start Trial   Start Trial
Panacea Biotec Ltd PRASUGREL prasugrel hydrochloride TABLET;ORAL 205897-002 Oct 16, 2017 AB RX No No   Start Trial   Start Trial   Start Trial
Hec Pharm PRASUGREL prasugrel hydrochloride TABLET;ORAL 206021-002 Jan 16, 2019 AB RX No No   Start Trial   Start Trial   Start Trial
Uspharma Windlas PRASUGREL prasugrel hydrochloride TABLET;ORAL 205790-002 Oct 16, 2017 AB RX No No   Start Trial   Start Trial   Start Trial
Accord Hlthcare PRASUGREL prasugrel hydrochloride TABLET;ORAL 205987-002 Feb 2, 2018 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
McKinsey
Baxter
Mallinckrodt
Merck
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.